Irhythm Holdings (IRTC) closed at $91.91 on November 13, 2026, down 1.8% from the previous close, on volume of 884,276 shares (30-day average 769,137).
Data as of November 13, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
Business Wire (Fri, 13-Nov 4:48 PM ET)
iRhythm Technologies Adopts New Executive Deferred Compensation Plan
TipRanks (Fri, 13-Nov 6:33 AM ET)
iRhythm Announces $200 Million Share Repurchase Program
TipRanks (Thu, 12-Nov 7:36 AM ET)
TipRanks (Thu, 12-Nov 6:40 AM ET)
Stocks to watch on Wednesday after hours: EZPW, IRTC, EGP
Seeking Alpha News (Wed, 11-Nov 4:43 PM ET)
iRhythm Holdings authorizes $200M share repurchase program
Seeking Alpha News (Wed, 11-Nov 4:10 PM ET)
iRhythm Announces Approval of $200 Million Share Repurchase Program
Globe Newswire (Wed, 11-Nov 4:05 PM ET)
PRNewswire (Fri, 6-Nov 4:43 PM ET)
iRhythm Holdings to Participate in Upcoming Investor Conferences
Globe Newswire (Fri, 6-Nov 9:15 AM ET)
iRhythm Holdings Announces Third Quarter 2026 Financial Results
Globe Newswire (Thu, 5-Nov 4:05 PM ET)
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Irhythm Holdings trades on the NASDAQ stock market under the symbol IRTC.
As of November 13, 2026, IRTC stock price declined to $91.91 with 884,276 million shares trading.
IRTC has a beta of 1.40, meaning it tends to be more sensitive to market movements. IRTC has a correlation of 0.12 to the broad based SPY ETF.
IRTC has a market cap of $3.02 billion. This is considered a Mid Cap stock.
Last quarter Irhythm Holdings reported $222 million in Revenue and $.82 earnings per share. This fell short of revenue expectation by $-649,952 and exceeded earnings estimates by $.78.
In the last 3 years, IRTC traded as high as $212.00 and as low as $55.92.
The top ETF exchange traded funds that IRTC belongs to (by Net Assets): VTI, VB, IWM, VBK, VXF.
IRTC has underperformed the market in the last year with a price return of -48.7% while the SPY ETF gained +11.5%. IRTC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.7% and -28.1%, respectively, while the SPY returned -2.1% and -1.9%, respectively.
IRTC support price is $90.82 and resistance is $96.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRTC shares will trade within this expected range on the day.
